Neil Archer Leads Bristol Myers Squibb Acquisition Through Disruption

19/07/2022 11 min Temporada 3 Episodio 5
Neil Archer Leads Bristol Myers Squibb Acquisition Through Disruption

Listen "Neil Archer Leads Bristol Myers Squibb Acquisition Through Disruption"

Episode Synopsis

In 2019, Bristol-Myers Squibb Company and Celgene Corporation announced to the world that they had entered into a definitive acquisition agreement. Bristol-Myers Squibb would acquire Celgene in a cash and stock transaction with an equity value of approximately $74 billion. It was the largest pharmaceutical acquisition in history.

More episodes of the podcast IQ Insigniam Quarterly® Audible